Financial navigation for Cancer

Kaiser Permanente Washington Health Research Institute, Seattle, WA
Financial navigation +1 moreN/AWaitlist AvailableLed by Matthew Banegas, PhD, MPH, MSResearch Sponsored by Kaiser Permanente

Study Summary

This trial is testing a financial navigation intervention to see if it impacts financial hardship, quality of life, cancer-related financial hardship, communication, and time to treatment.

Eligible Conditions
  • Cancer


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Financial distress
Health-related quality of life (cancer specific)
Secondary outcome measures
Financial hardship due to cancer care costs
Other outcome measures
Delinquent account
Initiation of cancer treatment
Out of pocket (OOP) expenditures
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Arm 3: Extended financial navigation interventionExperimental Treatment1 Intervention
Participants in this arm will receive their usual care, a Financial Resource Sheet and the brief intervention described in Arm 2 (i.e., one (1) cycle of financial navigation). Plus, they will receive two (2) additional cycles of financial navigation (total cycles: 3; total length: 6 months).
Group II: Arm 2: Brief financial navigation interventionExperimental Treatment1 Intervention
Participants in this arm will receive their usual care, and the Financial Resource Sheet described in Arm 1, plus one (1) cycle of financial navigation (total cycles: 1; total length: 6 months). In each intervention cycle participants will get at least one (1) phone call with a CAFÉ Financial Navigator, the navigator will talk with participants to identify financial questions or concerns. The navigator will create a personalized plan for each participant. Participants can request extra support from the navigator for up to 6 months.
Group III: Arm 1: Enhanced usual careActive Control1 Intervention
Participants in this arm will receive their usual care plus a Financial Resource Sheet. The financial resource sheet lists and describes existing organization and community resources available to KP members.

Find a site

Who is running the clinical trial?

Kaiser PermanenteLead Sponsor
518 Previous Clinical Trials
22,244,529 Total Patients Enrolled
Matthew Banegas, PhD, MPH, MSPrincipal Investigator
University of California, San Diego
Amanda Petrik, PhDC, MSPrincipal Investigator
Kaiser Permanente
Nora B Henrikson, PhD, MPHPrincipal Investigator
Kaiser Permanente

Media Library

Financial navigation Clinical Trial Eligibility Overview. Trial Name: NCT05018000 — N/A
Cancer Research Study Groups: Arm 1: Enhanced usual care, Arm 2: Brief financial navigation intervention, Arm 3: Extended financial navigation intervention
Cancer Clinical Trial 2023: Financial navigation Highlights & Side Effects. Trial Name: NCT05018000 — N/A
Financial navigation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05018000 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the enrollment size for this clinical experiment?

"Affirmative. records show that this medical trial, which was uploaded on August 11th 2021, is enrolment-active and looking for 370 patients at one location."

Answered by AI

Are any vacancies available for this research trial?

"Per, this trial is still open for enrollment as of August 15th 2022. The registration process was first launched on November 8th 2021."

Answered by AI
~40 spots leftby Dec 2023